Free Trial
NYSE:BME

BlackRock Health Sciences Trust (BME) Stock Price, News & Analysis

BlackRock Health Sciences Trust logo
$36.12 -0.25 (-0.69%)
As of 03:55 PM Eastern

About BlackRock Health Sciences Trust Stock (NYSE:BME)

Key Stats

Today's Range
$36.11
$36.60
50-Day Range
$34.88
$40.03
52-Week Range
$34.18
$42.64
Volume
29,313 shs
Average Volume
41,954 shs
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
7.89%
Price Target
N/A
Consensus Rating
N/A

Company Overview

BlackRock Health Sciences Trust is a closed-ended equity mutual fund launched by BlackRock, Inc. The fund is managed by BlackRock Advisors, LLC. It invests in the public equity markets of the United States. The fund seeks to invest in stocks of companies operating in the health sciences and related sectors, which include businesses involved in researching, developing, producing, distributing or delivering medical, dental, optical, pharmaceutical or biotechnology products, supplies, equipment, or services. It also invests through equity derivatives, with an emphasis on option writing. The fund benchmarks the performance of its portfolio against the Russell 3000 Healthcare Index. BlackRock Health Sciences Trust was formed on March 31, 2005 and is domiciled in the United States.

Receive BME Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for BlackRock Health Sciences Trust and its competitors with MarketBeat's FREE daily newsletter.

BME Stock News Headlines

It may already be too late…
A global energy shift is underway—and lithium is at the center of it. From electric vehicles to grid storage and consumer tech, demand for lithium is surging with no signs of slowing down. But here’s the problem: supply is struggling to keep up.
BME And FLC: There Are Still Pockets Of Opportunities
See More Headlines

BME Stock Analysis - Frequently Asked Questions

BlackRock Health Sciences Trust's stock was trading at $37.93 at the start of the year. Since then, BME stock has decreased by 4.8% and is now trading at $36.12.
View the best growth stocks for 2025 here
.

Top institutional shareholders of BlackRock Health Sciences Trust include Nova R Wealth Inc., Cornerstone Advisory LLC, LPL Financial LLC and Cambridge Investment Research Advisors Inc..
View institutional ownership trends
.

Shares of BME stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that BlackRock Health Sciences Trust investors own include Enterprise Products Partners (EPD), Verizon Communications (VZ), Mplx (MPLX), BlackRock Science and Technology Trust (BST), Johnson & Johnson (JNJ), Pfizer (PFE) and Main Street Capital (MAIN).

Company Calendar

Record date for 4/30 Dividend
4/15/2025
Ex-Dividend for 4/30 Dividend
4/15/2025
Dividend Payable
4/30/2025
Today
5/09/2025
Record date for 5/30 Dividend
5/15/2025
Ex-Dividend for 5/30 Dividend
5/15/2025
Dividend Payable
5/30/2025

Industry, Sector and Symbol

Stock Exchange
NYSE
Industry
Asset Management
Sub-Industry
Financial Services
Current Symbol
NYSE:BME
Fax
N/A
Employees
N/A
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
$24.07 million
Price / Cash Flow
N/A
Price / Book
N/A

Miscellaneous

Free Float
N/A
Optionable
Not Optionable
Beta
N/A
2025 Gold Forecast: A Perfect Storm for Demand Cover

Unlock the timeless value of gold with our exclusive 2025 Gold Forecasting Report. Explore why gold remains the ultimate investment for safeguarding wealth against inflation, economic shifts, and global uncertainties. Whether you're planning for future generations or seeking a reliable asset in turbulent times, this report is your essential guide to making informed decisions.

Get This Free Report

This page (NYSE:BME) was last updated on 5/9/2025 by MarketBeat.com Staff
From Our Partners